Related Experiment Video
Updated: Apr 11, 2026

04:14
Author Spotlight: In Vivo Assessment of Thyroid Hormone Disruption Using the THAI Mouse Model
Published on: October 6, 2023
1.4K
Congenital hypothyroidism screening program in iran; a systematic review and metaanalysis
Yousef Veisani1, Kourosh Sayehmiri2, Shahab Rezaeian3
1Student Research Committee.
Iranian Journal of Pediatrics
|May 29, 2015
Summary
Newborn screening for congenital hypothyroidism (CH) in Iran identified an incidence of 2/1000 neonates. Further research is needed to optimize TSH cut-off levels for accurate recall rates.
Area of Science:
- Neonatal screening
- Endocrinology
- Public health
Background:
- Congenital hypothyroidism (CH) can cause intellectual disability if not treated promptly.
- Early detection through newborn screening and timely thyroid hormone replacement is crucial for normal cognitive development.
Purpose of the Study:
- To systematically review and evaluate the national CH screening program results across Iranian provinces.
- To assess the incidence and recall rates of CH in Iran.
Main Methods:
- A systematic literature review of national and international databases (PubMed, Scopus, Web of Science, etc.).
- Meta-analysis of 25 studies involving 1,425,124 neonates using random-effects models.
- Exploration of heterogeneity using meta-regression.
Main Results:
- The pooled recall rate for TSH ≥5mIU/L was 0.014 (95% CI: 0.013-0.015).
- The overall incidence of CH was determined to be 2 per 1000 neonates (95% CI: 0.002-0.002).
- No significant increase in CH incidence over time was observed (P=0.08).
Conclusions:
- The current TSH cut-off of ≥5mIU/L for recalling neonates has a low positive predictive value (14%).
- Further research is required to establish more accurate TSH thresholds for neonatal recall.
- Optimizing screening criteria can improve the efficiency and accuracy of CH detection programs.
Related Concept Videos
Synthesis and Regulation of Thyroid Hormones
9.3K
Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
9.3K
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
261
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
261
Functions of Thyroid Hormones
7.0K
The thyroid hormone (TH) plays a pivotal role in the intricate orchestration of physiological processes, exerting profound effects on development, metabolism, and homeostasis throughout different life stages.
TH is indispensable for the normal development and maturation of the skeletal, muscular, and nervous systems during fetal and childhood growth. It facilitates bone mineral turnover and regulates protein synthesis in developing tissues, contributing significantly to overall growth and...
TH is indispensable for the normal development and maturation of the skeletal, muscular, and nervous systems during fetal and childhood growth. It facilitates bone mineral turnover and regulates protein synthesis in developing tissues, contributing significantly to overall growth and...
7.0K
Teratogenicity
4.6K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
4.6K

